Characteristics and short-term obstetric outcomes in a case series of 67 women test-positive for SARS-CoV-2 in Stockholm, Sweden.
Adult
COVID-19
/ diagnosis
COVID-19 Nucleic Acid Testing
/ methods
Delivery, Obstetric
/ methods
Female
Hospitalization
/ statistics & numerical data
Humans
Infant, Newborn
Infection Control
/ methods
Infectious Disease Transmission, Vertical
/ prevention & control
Male
Neonatal Screening
/ methods
Outcome and Process Assessment, Health Care
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Pregnancy Outcome
/ epidemiology
Premature Birth
/ epidemiology
Prenatal Care
/ methods
Retrospective Studies
SARS-CoV-2
/ isolation & purification
Sweden
/ epidemiology
COVID-19
SARS-CoV-2
delivery outcomes
pregnancy outcomes
preterm birth
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
18
06
2020
revised:
14
09
2020
accepted:
22
09
2020
pubmed:
28
9
2020
medline:
15
12
2020
entrez:
27
9
2020
Statut:
ppublish
Résumé
The Stockholm region was the first area in Sweden to be hit by the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The national guidelines on the care of women with a positive test for SARS-CoV-2 (detection with polymerase chain reaction [PCR]) recommend individualized antenatal care, mode of delivery based on obstetric considerations, and no routine separation of the mother and the newborn. Breastfeeding is encouraged, and although there is no specific recommendation regarding wearing a face mask to prevent viral transmission to the newborn while nursing, instructions are given to keep high hygiene standards. All studies based on cases tested on hospital admission will capture more women with pregnancy complications than in the general population. Our aim was to describe the clinical characteristics of SARS-CoV-2-positive women and their neonates, and to report short-term maternal and neonatal outcomes. A retrospective case series with data from medical records including all test-positive women (n = 67) who gave birth to 68 neonates from 19 March to 26 April 2020 in Stockholm, Sweden. Means, proportions and percentages were calculated for clinical characteristics and outcomes. The mean age was 32 years, 40% were nulliparous and 61% were overweight or obese. Further, 15% had diabetes and 21% a hypertensive disease. Seventy percent of the women had a vaginal birth. Preterm delivery occurred in 19% of the women. The preterm deliveries were mostly medically indicated, including two women who were delivered preterm due to severe coronavirus disease 19 (COVID-19), corresponding to 15% of the preterm births. Four women (6%) were admitted to the intensive care unit postpartum but there were no maternal deaths. There were two perinatal deaths (one stillbirth and one neonatal death). Three neonates were PCR-positive for SARS-CoV-2 after birth. In this case series of 67 women testing positive for SARS-CoV-2 with clinical presentations ranging from asymptomatic to manifest COVID-19 disease, few women presented with severe COVID-19 illness. The majority had a vaginal birth at term with a healthy neonate that was negative for SARS-CoV-2.
Identifiants
pubmed: 32981033
doi: 10.1111/aogs.14006
pmc: PMC7537005
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1626-1631Informations de copyright
© 2020 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG.
Références
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101826
pubmed: 32505805
Acta Obstet Gynecol Scand. 2020 Jul;99(7):948-949
pubmed: 32249924
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
Lakartidningen. 2019 Oct 8;116:
pubmed: 31593290
BJOG. 2020 Aug;127(9):1109-1115
pubmed: 32369656
Acta Obstet Gynecol Scand. 2018 Apr;97(4):466-476
pubmed: 29172245
Am J Obstet Gynecol. 2020 Dec;223(6):914.e1-914.e15
pubmed: 32553908
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
BJOG. 2020 Aug;127(9):1116-1121
pubmed: 32339382
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
Acta Obstet Gynecol Scand. 2020 Dec;99(12):1626-1631
pubmed: 32981033
J Matern Fetal Neonatal Med. 2022 Apr;35(8):1619-1622
pubmed: 32354293
Arch Pathol Lab Med. 2020 Apr 27;:
pubmed: 32338533
JAMA. 2020 Nov 3;324(17):1782-1785
pubmed: 32965467
Geburtshilfe Frauenheilkd. 2020 Apr;80(4):380-390
pubmed: 32322107
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Lancet Diabetes Endocrinol. 2016 Dec;4(12):1025-1036
pubmed: 27743975
Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4
pubmed: 32376317